Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation - Wikidata - wikimedia - TriplyDB

Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation

Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation

http://www.wikidata.org/entity/Q28267745

about

Control of the SOST bone enhancer by PTH using MEF2 transcription factors Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity Sclerostin Inhibition in the Management of Osteoporosis From disease to treatment: from rare skeletal disorders to treatments for osteoporosis Biological Events in Periodontal Ligament and Alveolar Bone Associated with Application of Orthodontic Forces Functions of the osteocyte network in the regulation of bone mass The DAN family: modulators of TGF-β signaling and beyond Control of bone mass and remodeling by PTH receptor signaling in osteocytes Characterization of the Structural Features and Interactions of Sclerostin: MOLECULAR INSIGHT INTO A KEY REGULATOR OF Wnt-MEDIATED BONE FORMATION Bone turnover markers in primary hyperparathyroidism.Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody Genetic evidence that SOST inhibits WNT signaling in the limb Mutational analysis of sclerostin shows importance of the flexible loop and the cystine-knot for Wnt-signaling inhibition Structure of neuroblastoma suppressor of tumorigenicity 1 (NBL1): insights for the functional variability across bone morphogenetic protein (BMP) antagonists.Single-pulsed electromagnetic field therapy increases osteogenic differentiation through Wnt signaling pathway and sclerostin downregulation.Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo.Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway Profile of romosozumab and its potential in the management of osteoporosis.Sclerostin-erbB-3 interactions: modulation of erbB-3 activity by sclerostin.Sclerostin: current knowledge and future perspectives.Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors Cellular mechanisms of bone remodeling Anti-Sclerostin antibody inhibits internalization of Sclerostin and Sclerostin-mediated antagonism of Wnt/LRP6 signaling.Differential expression of sclerostin in adult and juvenile mouse calvariae Role of Wnt signaling in fracture healing Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice Transcriptional Profiling of Laser Capture Microdissected Subpopulations of the Osteoblast Lineage Provides Insight Into the Early Response to Sclerostin Antibody in Rats.TIEG1-NULL OSTEOCYTES DISPLAY DEFECTS IN THEIR MORPHOLOGY, DENSITY AND SURROUNDING BONE MATRIX.Circulating sclerostin in disorders of parathyroid gland function.Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms.Sclerostin inhibition: a novel therapeutic approach in the treatment of osteoporosis.Plasma Sclerostin in HIV-Infected Adults on Effective Antiretroviral Therapy.Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.Expression of sclerostin in the developing zebrafish (Danio rerio) brain and skeleton.Sclerostin inhibits osteoblast differentiation without affecting BMP2/SMAD1/5 or Wnt3a/β-catenin signaling but through activation of platelet-derived growth factor receptor signaling in vitro Building bone to reverse osteoporosis and repair fractures A human bone morphogenetic protein antagonist is down-regulated in renal cancer Osteocytes, mechanosensing and Wnt signaling.

P2860

Q24337339-5AA1912B-7C43-4C37-BD28-994EC9808FCB Q24621990-8DDC75A6-4FD7-47C7-8307-1CE924AEBE75 Q24635850-E6034D15-0342-4B48-93EB-3E545BF0AE74 Q26750713-3B80F43C-4009-4D5B-94EA-2AA0747EC9C2 Q26764854-728EC8E7-F503-44E7-9228-C55D1CD2C815 Q26784032-4A3ABB3D-2CB5-4C2C-B81B-619DA4BEAA87 Q27002647-FA40C837-89BC-4FFB-9BE8-9049289804E4 Q27025762-CC64F326-17F7-4668-B045-762F6C85FD8D Q27300741-02D96130-4242-4049-818F-CFB4C3B2ADCF Q27653715-82E8286B-E753-406A-9B3F-CCFA2B1A28C4 Q27692682-2444AABC-F558-4C93-BEF5-C5F934F22E35 Q28286616-387E290F-F31F-4BFA-B902-9483032CD7CC Q28509512-8CB67813-35A7-4D14-A6E6-3F7E1D72514C Q28535490-20C3AFA9-9B1C-47D8-9B87-EA0867FB969A Q30090227-B91268E7-5368-4D0D-BBB9-9B4C969DD007 Q30278695-E4C12749-343C-4FA1-90BB-0ABB3AFB5BF7 Q30914003-382539C8-2215-41DA-AE7B-0830424705C1 Q31032805-DFEBBEDE-76AD-4DD7-A66D-A286ED67BD2C Q33596475-66FBB754-24A5-4FDA-A712-3BD102B64198 Q33720166-D240B442-9A64-416F-9C26-13381B660D93 Q33992612-CA1E4E42-8E96-4EF8-B1F2-C2BEBD86845F Q34328711-568E8173-E1A7-4FC9-9C46-711038FBAAA9 Q34428195-2287E8F1-02F0-4E47-9146-38179E868E66 Q34525829-C74C6C3B-F245-4B5E-8C77-3D95D994811F Q34701183-96BE267B-3906-4DCF-B488-383DAFC83342 Q34768838-9F3F8498-9FC1-47BF-8DE3-F1C385A5E604 Q35134403-152B2ECD-8386-443D-ADD4-E2F57FACFAF1 Q35156214-B75DA42D-1F8D-4275-A20B-26E05C7444D0 Q35560337-943A2065-3996-4A69-8769-F50DE608ADDF Q35569802-DD32CA58-5D2F-441B-827F-CF3A12FD77AC Q35597871-86952121-2382-419A-B0EF-5AF801F2A2E6 Q35609965-5148B2A7-0E13-4A86-8619-E6202A4627FE Q35694436-1A94483C-FCD2-4080-A26A-339B2F735C28 Q35861519-FE7DBD24-DBC3-473F-BE4D-D96CBD12E0E8 Q35983181-8112F3DF-138C-4E19-BF23-8607E4FE6EE3 Q36213693-BE6D272E-2D23-4198-B5FC-3A26080A1627 Q36256294-E98E2741-4320-4D80-8250-88328F161EF9 Q36407024-0133A2C0-0194-408E-B739-6DC775F8E48C Q36438780-B2CD9524-7AAE-4D9A-AC42-0C05DB68329A Q36595560-BE7E48D9-8910-4736-8DB7-54AE59AEB7D9

P2860

Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation

http://www.wikidata.org/entity/Q28267745

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Wnt but not BMP signaling is i ...... BMP-stimulated bone formation

@ast

Wnt but not BMP signaling is i ...... BMP-stimulated bone formation

@en

Wnt but not BMP signaling is i ...... BMP-stimulated bone formation

@nl

type

label

Wnt but not BMP signaling is i ...... BMP-stimulated bone formation

@ast

Wnt but not BMP signaling is i ...... BMP-stimulated bone formation

@en

Wnt but not BMP signaling is i ...... BMP-stimulated bone formation

@nl

prefLabel

Wnt but not BMP signaling is i ...... BMP-stimulated bone formation

@ast

Wnt but not BMP signaling is i ...... BMP-stimulated bone formation

@en

Wnt but not BMP signaling is i ...... BMP-stimulated bone formation

@nl

P1433

Q28267745-D5177EEB-6A72-438A-AC05-5CD14BB624FC

P1476

Q28267745-9649137E-5317-416F-93F3-41F42213CA64

P2093

Q28267745-0E4D6241-675E-442D-BECD-7210E4C6C855

Q28267745-1FEFC9B2-AA16-4B5C-804F-AEB15B95931F

Q28267745-2A80F134-477E-47A5-9F44-36F54D7112BC

Q28267745-4FC49CCD-D243-42B5-886F-E0D4D15EDBB3

Q28267745-5FFE5420-9C11-43F7-83C5-EA8EDC4A5656

Q28267745-92A2D883-3DD0-48AA-9DEC-695AAEAFFCDE

Q28267745-C319E293-9034-4C77-87CB-B44C5FD35847

Q28267745-D60B8FA5-07AE-4B37-90C4-02FD3051F662

P2860

Q28267745-80E868B9-C50C-46F7-8596-44442D743C1C

P304

Q28267745-6E39AFA5-715C-4E30-A932-30892ACD279B

P31

Q28267745-7004FD86-089C-4DAF-A4BC-D7429CEEF8AB

P3181

Q28267745-C1DAA5DF-B954-4AA4-8C47-19556A5ECC88

P356

Q28267745-9D21C787-CD42-4193-BBE2-570BD39F93D1

P407

Q28267745-4ABFD41D-51B3-4D09-BD80-A614686ABA52

P433

Q28267745-889DF5AC-EAA1-4073-BDBC-2BC5673D373A

P478

Q28267745-FF71EBDD-BDAA-4313-B907-6970259FC0DC

P50

Q28267745-9B9408C0-8B86-4DA4-9A51-5DA51F26DEE1

Q28267745-A702176E-6356-4F4F-97C4-097E6AFC32DE

Q28267745-FF8A3664-3BA9-4FAC-A6BF-64E86534B7CD

P577

Q28267745-BA304BA5-A7FA-48A5-8113-8DECF302423A

P5875

Q28267745-AA3C2FD8-24A1-4F1D-A2AB-87AF6EB9C50E

P698

Q28267745-5B4A7CE3-77E4-4028-9FF3-407290CB5DEB

P3181

P356

P1433

Journal of Bone and Mineral Research

P1476

Wnt but not BMP signaling is i ...... BMP-stimulated bone formation

@en

P2093

Annemieke Visser

http://www.w3.org/2001/XMLSchema#string

Clemens W G M Löwik

http://www.w3.org/2001/XMLSchema#string

Daniël Eefting

http://www.w3.org/2001/XMLSchema#string

Marcel Karperien

http://www.w3.org/2001/XMLSchema#string

Paul H A Quax

http://www.w3.org/2001/XMLSchema#string

Peter ten Dijke

http://www.w3.org/2001/XMLSchema#string

Rutger L van Bezooijen

http://www.w3.org/2001/XMLSchema#string

Socrates E Papapoulos

http://www.w3.org/2001/XMLSchema#string

P2860

Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease

P304

19-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4369244

http://www.w3.org/2001/XMLSchema#string

P356

10.1359/JBMR.061002

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

J Peter Svensson

Geertje van der Horst

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6763383

http://www.w3.org/2001/XMLSchema#string

P698

17032150

http://www.w3.org/2001/XMLSchema#string